Synonyms: BMS-986322 | BMS986322 | example 252 [US20210253554]
Compound class:
Synthetic organic
Comment: The chemical structure for lomedeucitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential. This was confirmed by a structure match in PubChem. Lomedeucitinib (BMS-986322) is administered orally. Information provided on BMS' pipeline webpage and other online resources suggests that lomedeucitinib inhibits the JAK family kinase TYK2, which is a recognised driver in systemic/autoimmune immune disorders (via IL-12 and IL-23-mediated TYK2 activation).
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel